Helena W Rodbard

15PUBLICATIONS
46CO-AUTHORS
Agricultural molecular engineering of nucleic acids and proteinsSport and exercise nutritionFood properties (incl. characteristics and health benefits)Cardiology (incl. cardiovascular diseases)Gene expression (incl. microarray and other genome-wide approaches)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (15)

|Jul 27, 2026
Efficacy and Safety of Once-Weekly Semaglutide 2.0 mg as an Add-On to Dose-Reduced Insulin Glargine versus Dose-Titrated Insulin Glargine in People With Type 2 Diabetes and Overweight (SUSTAIN OPTIMIZE).

|Mar 21, 2024
Practical strategies to manage obesity in type 2 diabetes.

Helena W Rodbard, Katharine Barnard-Kelly, Andreas F H Pfeiffer

|Oct 19, 2023
Gastrointestinal adverse events and weight reduction in people with type 2 diabetes treated with tirzepatide in the SURPASS clinical trials.

Hiren Patel, Kamlesh Khunti, Helena W Rodbard

|Oct 12, 2023
Proportion of participants with type 2 diabetes achieving a metabolic composite endpoint with once-weekly semaglutide treatment versus comparators: Post hoc pooled analysis from SUSTAIN 1-5, 7-10 and SUSTAIN China.

Linong Ji, A J Ahmann, B Ahrén

|Sep 26, 2023
Humanistic and Economic Burden of Patients with Cardiorenal Metabolic Conditions: A Systematic Review.

Keith C Ferdinand, Keith C Norris, Helena W Rodbard

|Mar 17, 2022
Managing weight and glycaemic targets in people with type 2 diabetes-How far have we come?

Matthias Blüher, Antonio Ceriello, Melanie Davies

Pageof 3

Frequent Collaborators

2 joint publications

Ildiko Lingvay

2 joint publications

Jake A Kushner

2 joint publications

Francesco Giorgino

2 joint publications

Thomas Danne